Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Depreciation and Depletion: 2019-2024

Historic Depreciation and Depletion for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to $5.5 million.

  • Relay Therapeutics' Depreciation and Depletion fell 45.28% to $748,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 22.03%. This contributed to the annual value of $5.5 million for FY2024, which is 3.70% up from last year.
  • Per Relay Therapeutics' latest filing, its Depreciation and Depletion stood at $5.5 million for FY2024, which was up 3.70% from $5.3 million recorded in FY2023.
  • Relay Therapeutics' Depreciation and Depletion's 5-year high stood at $5.5 million during FY2024, with a 5-year trough of $3.5 million in FY2020.
  • Moreover, its 3-year median value for Depreciation and Depletion was $5.3 million (2023), whereas its average is $5.0 million.
  • Data for Relay Therapeutics' Depreciation and Depletion shows a peak YoY rose of 27.58% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Relay Therapeutics' Depreciation and Depletion stood at $3.5 million in 2020, then increased by 10.59% to $3.9 million in 2021, then grew by 5.22% to $4.1 million in 2022, then climbed by 27.58% to $5.3 million in 2023, then grew by 3.70% to $5.5 million in 2024.